PRTN3 and rheumatoid arthritis: The aim of this study was not to find a direct relationship between the expression level of the tested molecule and the disease state or to conduct a functional study but to explore the possibility of using miRNAs as additional markers that may be helpful in diagnosing RA exacerbation or in identifying RA patients who are negative for serological markers such as the ACPA.